Candriam SCA’s Celcuity CELC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.59M Sell
72,588
-158,015
-69% -$18.2M 0.03% 317
2026
Q1
$26.3M Sell
230,603
-245,767
-52% -$26.8M 0.14% 159
2025
Q4
$47.5M Buy
476,370
+85,446
+22% +$7.02M 0.24% 95
2025
Q3
$19.3M Buy
390,924
+127,348
+48% +$5.1M 0.1% 184
2025
Q2
$3.52M Sell
263,576
-14
-0% -$152 0.02% 408
2025
Q1
$2.66M Hold
263,590
0.02% 445
2024
Q4
$3.45M Buy
+263,590
New +$3.72M 0.02% 414

Other funds holding CELC

Candriam SCA's CELC Position: Q2 2026 in Review

Candriam SCA reduced its Celcuity (CELC) stake by 69% in Q2 2026, selling an estimated $18.2M and leaving 72,588 shares worth $7.59M. The position accounts for 0.03% of the portfolio, ranked #317.

Candriam SCA first reported a position in CELC in Q4 2024 and has held it in 7 quarters since. The position peaked at $47.5M in Q4 2025. 274 funds tracked by Wall St. Rank hold CELC as of Q2 2026.

  • Candriam SCA held 72,588 shares of Celcuity worth $7.59M as of Q2 2026.
  • Candriam SCA sold 158,015 Celcuity shares in Q2 2026, an estimated $18.2M.
  • Celcuity made up 0.03% of Candriam SCA's portfolio in Q2 2026, its #317 holding.
  • Candriam SCA first reported a position in Celcuity in Q4 2024 and has held it in 7 quarters since.
  • Candriam SCA's Celcuity position peaked at $47.5M in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Celcuity as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.